Sakar Healthcare Expands European Footprint with New Anti-Cancer Injection Approvals 1 day ago Yesterday
Sakar Healthcare Ltd. has obtained its third and fourth marketing authorizations for oncology injections in the European market. The company is now preparing for commercial supply of these newly approved products, potentially opening up new revenue streams and strengthening its position in the oncology sector. This expansion into the European market with specialized oncology products is expected to diversify the company's market presence, offer revenue growth potential, and enhance its global standing in the pharmaceutical industry.
Sakar Healthcare Eyes EU Expansion with Anticipated MAS Approval for Oncology Products Jun 18, 2025
Sakar Healthcare Reports Impressive Q4 FY23 Results with Substantial Profit Growth May 15, 2025
Sakar Healthcare Achieves First EU Marketing Authorization for Oncology Injection Apr 21, 2025
Sakar Healthcare Expands Global Reach with 9 New Export Agreements Apr 16, 2025